CCDC47 blocking peptide
CCDC47 Peptide
Gene Names
CCDC47; GK001; MSTP041
Applications
Blocking (BL)
Synonyms
CCDC47; CCDC47 Peptide; GK001; MSTP041; Coiled-coil domain-containing protein 47; coiled-coil domain containing 47; CCDC47 blocking peptide
Form/Format
Liquid
Concentration
200 ug/mL (varies by lot)
Sequence Length
483
Applicable Applications for CCDC47 blocking peptide
Blocking (BL)
Application Notes
CCDC47 peptide is used for blocking the activity of CCDC47 antibody.
Species
Human
Buffer
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide
Location
16 amino acids near the carboxy terminus of human CCDC47.
Preparation and Storage
Store CCDC47 peptide at -20 degree C, stable for one year.
NCBI and Uniprot Product Information
NCBI GI #
NCBI GeneID
Molecular Weight
55,318 Da
NCBI Official Full Name
coiled-coil domain containing 47, isoform CRA_a
NCBI Official Synonym Full Names
coiled-coil domain containing 47
NCBI Official Symbol
CCDC47
NCBI Official Synonym Symbols
GK001; MSTP041
NCBI Protein Information
coiled-coil domain-containing protein 47
UniProt Protein Name
Coiled-coil domain-containing protein 47
Protein Family
UniProt Gene Name
CCDC47
UniProt Entry Name
CCD47_HUMAN
Uniprot Description
CCDC47: 2 isoforms of the human protein are produced by alternative splicing.
Protein type: Membrane protein, integral
Chromosomal Location of Human Ortholog: 17q23.3
Cellular Component: membrane; endoplasmic reticulum; integral to membrane
Molecular Function: protein binding; calcium ion binding
Biological Process: osteoblast differentiation; calcium ion homeostasis; ER overload response; post-embryonic development
Research Articles on CCDC47
Similar Products
Product Notes
The CCDC47 ccdc47 (Catalog #AAA152509) is a Blocking Peptide and is intended for research purposes only. The product is available for immediate purchase. AAA Biotech's CCDC47 can be used in a range of immunoassay formats including, but not limited to, Blocking (BL). CCDC47 peptide is used for blocking the activity of CCDC47 antibody. Researchers should empirically determine the suitability of the CCDC47 ccdc47 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process. It is sometimes possible for the material contained within the vial of "CCDC47, Blocking Peptide" to become dispersed throughout the inside of the vial, particularly around the seal of said vial, during shipment and storage. We always suggest centrifuging these vials to consolidate all of the liquid away from the lid and to the bottom of the vial prior to opening. Please be advised that certain products may require dry ice for shipping and that, if this is the case, an additional dry ice fee may also be required.Precautions
All products in the AAA Biotech catalog are strictly for research-use only, and are absolutely not suitable for use in any sort of medical, therapeutic, prophylactic, in-vivo, or diagnostic capacity. By purchasing a product from AAA Biotech, you are explicitly certifying that said products will be properly tested and used in line with industry standard. AAA Biotech and its authorized distribution partners reserve the right to refuse to fulfill any order if we have any indication that a purchaser may be intending to use a product outside of our accepted criteria.Disclaimer
Though we do strive to guarantee the information represented in this datasheet, AAA Biotech cannot be held responsible for any oversights or imprecisions. AAA Biotech reserves the right to adjust any aspect of this datasheet at any time and without notice. It is the responsibility of the customer to inform AAA Biotech of any product performance issues observed or experienced within 30 days of receipt of said product. To see additional details on this or any of our other policies, please see our Terms & Conditions page.Item has been added to Shopping Cart
If you are ready to order, navigate to Shopping Cart and get ready to checkout.
